Melodiol Global Health (ASX:ME1DE) Price-to-Tangible-Book : (As of Jun. 09, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Melodiol Global Health Price-to-Tangible-Book?

As of today (2024-06-09), Melodiol Global Health's share price is A$0.39. Melodiol Global Health's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was A$-0.97. Hence, Melodiol Global Health's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Melodiol Global Health's Price-to-Tangible-Book or its related term are showing as below:

During the past 8 years, Melodiol Global Health's highest Price to Tangible Book Ratio was 13.12. The lowest was 1.65. And the median was 4.87.

ASX:ME1DE's Price-to-Tangible-Book is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.265
* Ranked among companies with meaningful Price-to-Tangible-Book only.

A closely related ratio is called PB Ratio. As of today, Melodiol Global Health's share price is A$0.39. Melodiol Global Health's Book Value per Sharefor the quarter that ended in Dec. 2023 was A$-0.52. Hence, Melodiol Global Health's P/B Ratio of today is .

Melodiol Global Health Price-to-Tangible-Book Historical Data

The historical data trend for Melodiol Global Health's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Melodiol Global Health Price-to-Tangible-Book Chart

Melodiol Global Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.65

13.12

5.17

5.70

Melodiol Global Health Semi-Annual Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial										5.17	2.40	5.70	-	-

Competitive Comparison of Melodiol Global Health's Price-to-Tangible-Book

For the Drug Manufacturers - Specialty & Generic subindustry, Melodiol Global Health's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Melodiol Global Health's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Melodiol Global Health's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Melodiol Global Health's Price-to-Tangible-Book falls into.

Melodiol Global Health Price-to-Tangible-Book Calculation

Melodiol Global Health's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	0.39	/	-0.971
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Melodiol Global Health Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Melodiol Global Health's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Melodiol Global Health (ASX:ME1DE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Melodiol Global Health Ltd (ASX:ME1DE) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

COPHF:USA

Address

145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009

Website

https://www.cresopharma.com

Melodiol Global Health Ltd is engaged in developing, registering, and commercialization of pharmaceutical-grade cannabis and hemp-based nutraceutical products and treatments for human and animal health. Its brands include Mernova: A licensed producer of cannabis products in Canada for sale under the Ritual brand banner. Sierra Sage Herbs: US-based developer of plant-based, beauty, and personal care brands Green Goo, Southern Butter, and Good Goo. impACTIVE: CBD topical products for athletes. Halucenex: Clinical stage psychedelics research and development operation. Creso Pharma Switzerland: CBD-related research, development, and commercialization.

Melodiol Global Health (ASX:ME1DE) Headlines

No Headlines